Robert Eil
Impact in
- Immunology top 2%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- T-cell and B-cell Immunology
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in ⓘ
- Oncology 18
- CAR-T cell therapy research 7
- Colorectal Cancer Treatments and Studies 4
- Pancreatic and Hepatic Oncology Research 4
- Cancer Immunotherapy and Biomarkers 3
- Immunology 14
- Immune Cell Function and Interaction 10
- T-cell and B-cell Immunology 8
- Co-authors
- Nicholas P. Restifo (12 shared papers)Rahul Roychoudhuri (10 shared papers)Christopher A. Klebanoff (9 shared papers)Madhusudhanan Sukumar (7 shared papers)Douglas C. Palmer (7 shared papers)Zhiya Yu (5 shared papers)Tori N. Yamamoto (6 shared papers)Suman K. Vodnala (5 shared papers)
- Journals
- The American Journal of Surgery (3 papers)The Journal of Experimental Medicine (2 papers)Journal of Clinical Oncology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Cancer Immunology Research (2 papers)
- Partner nations
- United StatesUnited KingdomHungary
In The Last Decade
Robert Eil
29 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Immunology 1.0k
- Oncology 1.1k
- Cancer Research 222
- Molecular Biology 739
- Physiology 42
Countries citing papers authored by Robert Eil
This map shows the geographic impact of Robert Eil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Eil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Eil more than expected).
Fields of papers citing papers by Robert Eil
This network shows the impact of papers produced by Robert Eil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Eil. The network helps show where Robert Eil may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Eil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ionic immune suppression within the tumour microenvironment limits T cell effector function Hit paper breakdown → | 2016 | 489 |
| 2 | T cell stemness and dysfunction in tumors are triggered by a common mechanism Hit paper breakdown → | 2019 | 409 |
| 3 | 2016 | 199 | |
| 4 | 2017 | 160 | |
| 5 | 2015 | 139 | |
| 6 | 2020 | 116 | |
| 7 | 2015 | 114 | |
| 8 | 2019 | 110 | |
| 9 | 2021 | 55 | |
| 10 | 2017 | 51 | |
| 11 | 2016 | 47 | |
| 12 | 2020 | 46 | |
| 13 | 2013 | 36 | |
| 14 | 2023 | 18 | |
| 15 | 2022 | 12 | |
| 16 | 2021 | 11 | |
| 17 | 2023 | 8 | |
| 18 | Bile duct involvement portends poor prognosis in resected gallbladder carcinoma. | 2013 | 7 |
| 19 | 2024 | 6 | |
| 20 | 2015 | 5 |
About Robert Eil
Robert Eil is a scholar working on Oncology, Immunology, Hepatology, Surgery and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 2.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (8 papers), CAR-T cell therapy research (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Colorectal Cancer Treatments and Studies (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), CRISPR and Genetic Engineering (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Immunology (1.0k citations), Oncology (1.1k citations), Cancer Research (222 citations), Molecular Biology (739 citations) and Physiology (42 citations). Robert Eil has collaborated with scholars based in United States, United Kingdom and Hungary. Frequent co-authors include Nicholas P. Restifo, Rahul Roychoudhuri, Christopher A. Klebanoff, Madhusudhanan Sukumar, Douglas C. Palmer, Zhiya Yu, Tori N. Yamamoto, Suman K. Vodnala, David Clever and Shashank J. Patel. Their work appears in journals such as The American Journal of Surgery, The Journal of Experimental Medicine, Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.